Background The extravascular (EV) implantable cardioverter-defibrillator (ICD) includes
features to address sensing and arrhythmia detection challenges presented by its substernal …

Objectives This study reports the sensing and arrhythmia detection performance of a novel
extravascular (EV) implantable cardioverter-defibrillator (ICD) in a first-in-human pilot study …

Abstract Background The investigational Extravascular Implantable Cardioverter Defibrillator
(EV ICD) is an implantable defibrillator with defibrillation and pacing therapies, including the …

Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator
sensed and successfully treated as a result of oversensing - ScienceDirect Skip to main …

Implantable cardioverter-defibrillators (ICDs) reduce mortality in patients at risk of sudden
cardiac death. 1–3 Transvenous lead-related complications 4–6 have prompted the …

Objectives The aim of this study was to evaluate the safety and performance of an
extravascular (EV) implantable cardioverter-defibrillator (ICD). Background Limitations of …

Abstract Ventricular fibrillation (VF), uninterrupted, is fatal within minutes. Implantable
cardioverter defibrillators (ICDs) sense ventricular electrograms (EGMs) during VF and …

Background The purpose of this study was to prospectively analyze redetection problems
after unsuccessful shock with different lead systems and devices. Methods and Results We …

Background A novel extravascular (EV) ICD lead (AtaCor Medical, San Clemente, CA) is
under development for sensing and defibrillation of ventricular tachyarrhythmias (VF) using …

Background Implantable defibrillators (ICD) are highly effective in reducing arrhythmia‐
related mortality. ICD shock therapy has been shown to increase psychological distress …